SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Persistence
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
Moderator
Mary Kearney
National Cancer Institute, Frederick, MD, United States
Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir
Afam A. Okoye
Vaccine & Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States
CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART
Joseph K. Wong
University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States
Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence
Thor A. Wagner
University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States
Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo
Gregory M. Laird
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy
Khader Ghneim
VGTI-FL, Port Saint Lucie, FL, United States
Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control
Gary Blick
Circle Care Center, Norwalk, CT, United States
Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir
Kai Deng
The Johns Hopkins University, Baltimore, MD, United States
Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART
Bernard J. Macatangay
Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption
Timothy J. Henrich
Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
10 of
10
|
